Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pregnancies and offspring after MOPP therapy].

J M Andrieu, M E Ochoa-Molina

    La Nouvelle Presse Medicale
    |December 4, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.

    Journal of internal medicine·2007
    Same author

    Metastatic undifferentiated nasopharyngeal carcinoma (UCNT) can present as isolated cervical lymphadenopathy.

    Histopathology·2006
    Same author

    Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.

    Bone marrow transplantation·2002
    Same author

    [Thyroid cancer: pathological anatomy, diagnosis].

    La Revue du praticien·2002
    Same author

    In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells.

    Journal of virology·2001
    Same author

    Enhanced dendritic cell-driven proliferation and anti-HIV activity of CD8(+) T cells by a new phenothiazine derivative, aminoperazine.

    Journal of immunology (Baltimore, Md. : 1950)·2001

    MOPP chemotherapy for Hodgkin

    Area of Science:

    • Oncology
    • Reproductive Medicine
    • Teratology

    Context:

    • Investigating the long-term effects of chemotherapy on reproductive health is crucial for cancer survivors.
    • MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) was a standard treatment for Hodgkin's disease.
    • Understanding the impact of MOPP on fertility and offspring is essential for patient counseling and care.

    Purpose:

    • To assess the influence of MOPP chemotherapy on fertility, pregnancy outcomes, and congenital abnormalities in women treated for Hodgkin's disease.
    • To evaluate the psychomotor development of children born to mothers treated with MOPP.
    • To determine if MOPP therapy affects reproductive capacity and offspring health in women who maintain menstruation post-treatment.

    Summary:

    Related Experiment Videos

  • A retrospective questionnaire study analyzed 68 women treated with MOPP for Hodgkin's disease (1972-1976).
  • Pre-treatment: 36 women had 72 pregnancies, 31 live births, with 2 minor congenital abnormalities.
  • Post-treatment: 22 women (of 50 menstruating) had 30 pregnancies, 22 live births, with 1 minor congenital malformation and normal psychomotor development in all offspring.

    • Impact:

    • MOPP chemotherapy does not appear to adversely affect fertility, pregnancy, or offspring in women who continue menstruating after treatment.
    • This finding supports the possibility of successful pregnancies and healthy offspring in Hodgkin's disease survivors treated with MOPP.
    • The study highlights the importance of continued menstruation as an indicator of preserved reproductive function post-chemotherapy.